Cargando…

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition

BACKGROUND: We aimed to assess the hospital economic costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. METHODS: A retrospective study of all hospital admissions between January 1, 2005, and December 31, 2006 was carried out in a 420-bed, urban, tertiary-care teaching hospi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales, Eva, Cots, Francesc, Sala, Maria, Comas, Mercè, Belvis, Francesc, Riu, Marta, Salvadó, Margarita, Grau, Santiago, Horcajada, Juan P, Montero, Maria Milagro, Castells, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412693/ https://www.ncbi.nlm.nih.gov/pubmed/22621745 http://dx.doi.org/10.1186/1472-6963-12-122

Ejemplares similares

Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona
por: Riu, Marta, et al.
Publicado: (2016)

Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital
por: Riu, Marta, et al.
Publicado: (2017)

ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa
por: Puig-Collderram, Berta, et al.
Publicado: (2022)

Descriptive analysis of childbirth healthcare costs in an area with high levels of immigration in Spain
por: Comas, Mercè, et al.
Publicado: (2011)

Budget Impact Analysis of Switching to Digital Mammography in a Population-Based Breast Cancer Screening Program: A Discrete Event Simulation Model
por: Comas, Mercè, et al.
Publicado: (2014)

Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?
por: Montero, María Milagro, et al.
Publicado: (2020)

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
por: Sorlí, Luisa, et al.
Publicado: (2017)

Time-trend and variations in the proportion of second-eye cataract surgery
por: Hoffmeister, Lorena, et al.
Publicado: (2007)

Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization
por: Sala, Maria, et al.
Publicado: (2014)

Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates
por: Montero, María Milagro, et al.
Publicado: (2022)

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence
por: Lopez-Montesinos, Inmaculada, et al.
Publicado: (2022)

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition
por: Suarez, Cristina, et al.
Publicado: (2011)

Spontaneous Nosocomial Pseudomonas aeruginosa Meningitis Presenting as Trismus
por: Parr, C. J., et al.
Publicado: (2017)

Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study
por: López Montesinos, Inmaculada, et al.
Publicado: (2021)

Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain
por: Posso, Margarita, et al.
Publicado: (2020)

Impact of immigration on the cost of emergency visits in Barcelona (Spain)
por: Cots, Francesc, et al.
Publicado: (2007)

Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people
por: Buron, Andrea, et al.
Publicado: (2017)

Imipenem-Resistant Pseudomonas aeruginosa: Risk Factors for Nosocomial Infections
por: Onguru, Pinar, et al.
Publicado: (2008)

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
por: Lu, Qin, et al.
Publicado: (2014)

Cost-effectiveness of early detection of breast cancer in Catalonia (Spain)
por: Carles, Misericordia, et al.
Publicado: (2011)

Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers
por: Knobel, Pablo, et al.
Publicado: (2021)

Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial
por: Montero-Moraga, Jose Maria, et al.
Publicado: (2021)

Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model
por: Montero, María M., et al.
Publicado: (2021)

339 An International, Multicenter, Retrospective Study of Nosocomial Pneumonia due to Pseudomonas aeruginosa
por: Micek, Scott, et al.
Publicado: (2014)

Nosocomial Acquisition of Dengue
por: Wagner, Dirk, et al.
Publicado: (2004)

Hospital emergency department utilisation rates among the immigrant population in Barcelona, Spain
por: Buron, Andrea, et al.
Publicado: (2008)

Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study
por: Rozenkiewicz, Dawid, et al.
Publicado: (2021)

Long-term costs of colorectal cancer treatment in Spain
por: Corral, Julieta, et al.
Publicado: (2016)

Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates
por: Montero, María M., et al.
Publicado: (2021)

Role of Relebactam in the Antibiotic Resistance Acquisition in Pseudomonas aeruginosa: In Vitro Study
por: Ventero, Maria Paz, et al.
Publicado: (2023)

Club Cell protein: a candidate diagnostic biomarker of Pseudomonas aeruginosa nosocomial pneumonia
por: Moroz, V, et al.
Publicado: (2014)

Prevalence of Virulence Genes Among Bulgarian Nosocomial and Cystic Fibrosis Isolates of Pseudomonas Aeruginosa
por: Mitov, Ivan, et al.
Publicado: (2010)

An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance
por: Micek, Scott T, et al.
Publicado: (2015)

Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa
por: Sonmezer, Meliha Cagla, et al.
Publicado: (2016)

Nosocomial Infections with IMP-19−Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France
por: Amoureux, Lucie, et al.
Publicado: (2017)

Epidemiology and high incidence of metallo-β-lactamase and AmpC-β-lactamases in nosocomial Pseudomonas aeruginosa
por: Muddassir, Maria, et al.
Publicado: (2021)

Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort Study
por: Terradas, Roser, et al.
Publicado: (2012)

Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs
por: Romero, Anabel, et al.
Publicado: (2016)

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Esteve-Palau, Erika, et al.
Publicado: (2018)

Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa
por: Marra, Alexandre R, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_cftvfg9utl6bg8tjtf53djfa5p